Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Operating Leases (2019 - 2025)

Historic Operating Leases for vTv Therapeutics (VTVT) over the last 7 years, with Q1 2025 value amounting to $125000.0.

  • vTv Therapeutics' Operating Leases fell 5805.37% to $125000.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $125000.0, marking a year-over-year decrease of 5805.37%. This contributed to the annual value of $169000.0 for FY2024, which is 0.0% changed from last year.
  • vTv Therapeutics' Operating Leases amounted to $125000.0 in Q1 2025, which was down 5805.37% from $169000.0 recorded in Q4 2024.
  • Over the past 5 years, vTv Therapeutics' Operating Leases peaked at $633000.0 during Q1 2021, and registered a low of $125000.0 during Q1 2025.
  • For the 5-year period, vTv Therapeutics' Operating Leases averaged around $390470.6, with its median value being $417000.0 (2023).
  • Its Operating Leases has fluctuated over the past 5 years, first soared by 294.78% in 2023, then crashed by 5805.37% in 2025.
  • Quarter analysis of 5 years shows vTv Therapeutics' Operating Leases stood at $492000.0 in 2021, then crashed by 31.3% to $338000.0 in 2022, then tumbled by 50.0% to $169000.0 in 2023, then changed by 0.0% to $169000.0 in 2024, then decreased by 26.04% to $125000.0 in 2025.
  • Its Operating Leases was $125000.0 in Q1 2025, compared to $169000.0 in Q4 2024 and $213000.0 in Q3 2024.